Listen to this story
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowThis audio file is brought to you by 
0:00
0:00
Loading audio file, please wait.
Biomet Inc. has agreed to pay $600,000 in legal fees and make additional information available to shareholders in order to settle class-action lawsuit opposing its pending sale to a group of private equity firms, the Warsaw prosthetics maker said in a Securities and Exchange Commission filing yesterday.
The settlement isn’t expected to affect the $10.9 billion purchase price by LVB Acquisition LLC, Goldman Sachs & Co., Kohlberg Kravis Roberts and Texas Pacific Group, Biomet said. Shareholders are scheduled to vote June 8.
Please enable JavaScript to view this content.